NCT00334659View on ClinicalTrials.gov

A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

37

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions

HIV Infections

Interventions

DRUG

apricitabine

Trial Locations (1)

49007

Jasper Clinic Inc., Kalamazoo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Avexa

INDUSTRY

NCT00334659 - A Study to Investigate the Cardiovascular Safety of Apricitabine in Healthy Subjects | Biotech Hunter | Biotech Hunter